Medical specialists from Canada tagged as investigators in clinical trials studying Hyperlipidemias
Total 12 results
-
Charlotte A Jones, PhD MDSeen in:
- Alberta, Calgary, Calgary Safeway Pharmacy - Crowfoot Location
Trials:- NCT00626041 (Principal Investigator)
Conditions: -
Chris Williams, MD CCFPSeen in:
- Ontario, Burlington, Caroline Medical Group
Trials:- NCT00291824 (Sub-Investigator)
Conditions: -
Colleen MaythamSeen in:
- British Columbia, Kelowna, OCT Research ULC
Trials:- NCT05256654 (Principal Investigator)
-
Daniel GaudetSeen in:
- Quebec, Chicoutimi, Ecogene-21
- Quebec, Chicoutimi, Ecogene-21 - Cmas
Trials:- NCT05256654 (Principal Investigator)
- NCT05556512 (Principal Investigator)
- NCT05882045 (Principal Investigator)
- NCT05891834 (Principal Investigator)
- NCT06292013 (Principal Investigator)
- NCT06383390 (Principal Investigator)
-
David Wallik, MD CCFPSeen in:
- Ontario, Burlington, Caroline Medical Group
Trials:- NCT00291824 (Sub-Investigator)
Conditions: -
Gary F Lewis, MDSeen in:
- Ontario, Toronto, Tornto General Hospital, UHN
Trials:- NCT05103761 (Principal Investigator)
- NCT03860688 (Principal Investigator)
Conditions: -
James Kraemer, MD CCFPSeen in:
- Ontario, Burlington, Caroline Medical Group
Trials:- NCT00291824 (Sub-Investigator)
Conditions: -
Jean BergeronSeen in:
- Quebec, Québec, Clinique des Maladies Lipidiques de Québec
Trials:- NCT05256654 (Principal Investigator)
- NCT06292013 (Principal Investigator)
-
Lori Chalklin, MD CCFPSeen in:
- Ontario, Burlington, Caroline Medical Group
Trials:- NCT00291824 (Sub-Investigator)
Conditions: -
Raja ChehayebSeen in:
- Quebec, Greenfield Park, Viacar Recherche Clinique
Trials:- NCT05256654 (Principal Investigator)
- NCT05936151 (Principal Investigator)
-
Stephen Duncan, MD CCFPSeen in:
- Ontario, Burlington, Caroline Medical Group
Trials:- NCT00291824 (Sub-Investigator)
Conditions: -
Subodh VermaSeen in:
- Ontario, North York, North York Diagnostic and Cardiac Centre
Trials:- NCT05256654 (Principal Investigator)
- NCT05556512 (Principal Investigator)
- NCT05592275 (Principal Investigator)
- NCT05882045 (Principal Investigator)
- NCT05936151 (Principal Investigator)
- NCT06292013 (Principal Investigator)
- NCT06383390 (Principal Investigator)
Conditions:- Metabolic Diseases;
- Dyslipidemias;
- Lipid Metabolism Disorders;
- Hyperlipoproteinemia;
- Obesity;
- Overweight;
- Heart Failure;
- Heart Failure With Preserved Ejection Fraction;
- Cardiovascular Diseases;
- Type 2 Diabetes;
- CKD;
- Overweight or Obesity;
- Elevated Lp(a);
- Atherosclerotic Cardiovascular Disease (ASCVD);
- Overweight and Obesity
Clinical Trials on Hyperlipidemias
-
Arrowhead PharmaceuticalsRecruitingHypertriglyceridemiaUnited States
-
Federico II UniversityRecruiting
-
ValbiotisRecruiting
-
Suzhou Sanegene Bio Inc.Not yet recruiting
-
Shanghai Junshi Bioscience Co., Ltd.Recruiting
-
Kowa Company, Ltd.Recruiting
-
Marea TherapeuticsRecruiting
-
SunWay Biotech Co., LTD.Not yet recruitingHyperlipidemias
-
Federico II UniversityRecruitingHypercholesterolemiaItaly
-
Assistance Publique Hopitaux De MarseilleRecruiting